A Randomised trial of anti-GM-CSF Otilimab in severe COVID-19 pneumonia (OSCAR)

Patel J, Bass D, Beishuizen A, Bocca Ruiz X, Boughanmi H, Cahn A, Colombo H, Criner GJ, Davy K, de-Miguel-Díez J, Doreski PA, Fernandes S, François B, Gupta A, Hanrott K, Hatlen T, Inman D, Isaacs JD, Jarvis E, Kostina N, Kropotina T, Lacherade JC, Lakshminarayanan D, Martinez-Ayala P, McEvoy C, Meziani F, Monchi M, Mukherjee S, Muñoz-Bermúdez R, Neisen J, O'Shea C, Plantefeve G, Schifano L, Schwab LE, Shahid Z, Shirano M, Smith JE, Sprinz E, Summers C, Terzi N, Tidswell MA, Trefilova Y, Williamson R, Wyncoll D, Layton M. A Randomised trial of anti-GM-CSF Otilimab in severe COVID-19 pneumonia (OSCAR). Eur Respir J. 2022 Oct 13:2101870. doi: 10.1183/13993003.01870-2021. Epub ahead of print. PMID: 36229048.


Related Posts